Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex

Journal of Alzheimer's Disease

Volumn 6, Issue 3, 2004, Pages 209-219

  Echeverria, Valentina ^a   Ducatenzeiler, Adriana ^a   Alhonen, Leena ^b   Janne, Juhani ^b   Grant, Susan M ^a   Wandosell, Francisco ^c   Muro, Andres ^d   Baralle, Francisco ^d   Li, Hongshan ^e   Duff, Karen ^f   Szyf, Moshe ^a   Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^e Ciphergen   (Canada)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Amyloid ; ERK MAPK; Tau phosphorylation; Transgenic rat

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; EPITOPE; GLYCOGEN SYNTHASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PRESENILIN 1; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOUBLE TRANSGENIC RAT; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN PRESENILIN 1 TRANSGENE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RAT; SENILE PLAQUE; TAU PHOSPHORYLATION; TRANSGENE; TRANSGENIC ANIMAL; TRANSGENIC RAT;

EID: 3042622487     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6301     Document Type: Article

References (41)

1. J.A. Hardy and G.A. Higgins, Alzheimer's disease: The amyloid cascade hypothesis, Science 256(5054) (1992), 184-185.
2. F. Van Leuven, Single and multiple transgenic mice as models for Alzheimer's disease, Prog. Neurobiol. 61 (2000), 305-312.
3. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson and F. Gillespie, et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature 373 (1995), 523-527.
4. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey and P.A. Paganetti, et al., Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc. Natl. Acad. Sci. USA 94 (1997), 13287-13292.
5. D. Moechars, K. Lorent and F. Van Leuven, Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis, Neuroscience 91 (1999), 819-830.
6. T.P. Wong, T. Debeir, K. Duff and A.C. Cuello, Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes, J. Neurosci. 19 (1999), 2706-2716.
7. J. Larson, G. lynch, D. Games and P. Seubert, Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice, Brain Res 840 (1999), 23-35.
8. H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, B. Chromy, K.L. Viola, W.L. Klein, W.B. Stine, G.A. Krafft and B.L. Trommer, Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus, Brain Res 924 (2002), 133-140.
9. P.F. Chapman, G.L. White, M.W. Jones, D. Cooper-Blacketer, V.J. Marshall, M. Irizarry, L. Younkin, M.A. Good, T.V. Bliss and B.T. Hyman, et al., Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice, Nat. Neurosci. 2 (1999), 271-276.
10. K. Hsiao, et al., Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science 274 (1996), 99-102.
11. M.C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao and B.T. Hyman, APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1, J. Neuropathol. Exp. Neurol. 56 (1997), 965-973.
12. B. Kolb and I.Q. Whishaw, Introduction to brain and behavior (W.H Freeman & Co, New York, NY), (2001).
13. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, B. Winblad and L. Lannfelt, A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid, Nat. Genet. 1 (1992), 345-347.
14. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving and L. James, et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
15. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Pereztur, M. Hutton, L. Buee, Y. Harigaya and D. Yager, et al., Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1, Nature 383 (1996), 710-713.
16. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen and L.R. Pease, Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension, Gene 77 (1989), 51-59.
17. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton and W. Kukull, et al., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med 2 (1996), 864-870.
18. N. Blin and D.W. Stafford, A general method for isolation of high molecular weight DNA from eukaryotes, Nucleic Acids Res 3 (1976), 2303-2308.
19. B. Sommer, M. Kohler, R. Sprengel and P.H. Seeburg, RNA editing in brain controls a determinant of ion flow in glutamate-gated channels, Cell 67 (1991), 11-19.
20. M. Halmekyto, et al., Transgenic mice aberrantly expressing human ornithine decarboxylase gene, J. Biol. Chem. 266 (1991), 19746-19751.
21. S.M. Grant, A. Ducatenzeiler, M. Szyf and A.C. Cuello, Aβ immunoreactive material is present in several intracellular compartments in transfected, neuronally differentiated, P19 cells expressing the human amyloid β-protein precursor, J Alz. Dis. 2 (2000), 207-222.
22. W.J. Ryves et al Ryves and A.J. Harwood, Lithium inhibits glycogen synthase kinase-3 by competition for magnesium, Biochem. Biophys. Res. Commun. 280(3) (2001), 720-725.
23. C.L. Sayas, M.T. Moreno-Flores, J. Avila and F.J. Wandosell, The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation, J Biol Chem 274(52) (1999), 3704-3752.
24. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicol and L. Mucke, Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models, Proc Natl Acad Sci USA 96(6) (1999), 3228-3233.
25. I. Ferrer, et al., Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration, Brain Pathol 11 (2001), 144-158.
26. K.K. Hsiao, Understanding the biology and molecular pathogenesis of Alzheimer's disease in transgenic mice expressing amyloid precursor proteins, in: Molecular mechanism of dementia. Totowa, W. Wasco and R.E. Tanzi, eds, NJ: Humana press, 1997, pp. 39-44.
27. G.K. Gouras, et al., Intraneuronal Ab42 accumulation in human brain, Am. J. Pathol. 156 (2000), 15-20; 256 (1992), 184-185.
28. G.K. Gouras, et al., Intraneuronal Ab42 accumulation in human brain, Am. J. Pathol. 156 (2000), 15-20; 256 (1992), 184-185.
29. S.M. Grant, A. Morinville, D. Maysinger, M. Szyf and A.C. Cuello, Phosphorylation of mitogen-activated protein kinase is altered in neuroectodermal cells overexpressing the human amyloid precursor protein 751 isoform, Mol Brain Res 72 (1999), 115-120.
30. C. Mori, E.T. Spooner, K.E. Wisniewsk, T.M. Wisniewski, H. Yamaguch, T.C. Saido, D.R. Tolan, D.J. Selkoe and C.A. Lemere, Intraneuronal Abeta42 accumulation in Down syndrome brain, Amyloid 9(2) (2002), 88-102.
31. R.H. Takahashi, E.E. Nam, M. Edgar and G.K. Gouras, Alzheimer beta-amyloid peptides: normal and abnormal localization, Histol. Histopathol. 17 (2002), 239-246.
32. T. Iwatsubo, D.M. Mann, A. Odaka, N. Suzuki and Y. Ihara, Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome, Ann. Neurol. 37 (1995), 294-299.
33. P.M. Matthews, A.M. Cataldo, B.H. Kao, A.G. Rudnicki, X. Qin, J.L. Yang, Y. Jiang, M. Picciano, Ch. Hulette, C.F. Lippa, T.D. Bird, D. Nochlin, J. Walter, Ch. Haas, L. Levesque, P.E. Fraser, A. Andreadis and R.A. Nixon, Brain Expression of presenilins in Sporadic and Early-onset, familial Alzheimer's Disease, Molecular Medicine 6(10) (2000), 878-891.
34. T. Hartman, Intracellular biology of Alzheimer's disease amyloid beta peptide, Eur Arch Psychiatry Clin Neurosci 249(6) (1999), 291-298.
35. V. Echeverria and A.C. Cuello, Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol 26(2-3) (2002), 299-316.
36. D.G. Cook, M.S. Forman, J.C. Sung, S. Leight, D.L. Kolson, T. Iwatsubo, V.M. Lee and R.W. Doms, Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nature Med 3 (1997), 1021-1023.
37. V. Echeverria, E. Dowd, L. Alhonen, K. Duff, A. Ducantenzeiler, S. Grant, M. Szyf, F. Wandossel, J. Avila and A.C. Cuello, A rat transgenic model over expressing intraneuronal human a peptide shows tau hyperphosphorylation and mapk activation. 32nd Society for Neuroscience Annual Meeting, November 5, 2002, Slide Presentation 522.3.
38. S. Impey, K. Obrietan and D.R. Storm, Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity, Neuron 23 (1999), 11-14.
39. F.G.G. Vercauteren, J.J.M. Bergeron, A. Bell, L. Alhonen, J. Janne, P.S. McPherson, M. Szyf, F. Vandesabde and A.C. Cuello, 32nd Society for Neuroscience Annual Meeting, November 5, 2002, Poster Presentation 295.4.
40. E. Valjent, J. Caboche and P. Vanhoutte, Mitogen-Activated protein kinase/extracellular signal- regulated kinase induced gene regulation in brain, Molecular Neurobiology 23(2/3) (2001), 83-99.
41. F.G.G. Vercauteren, S. Clerens, J.J.M. Bergeron, L. Arkens, F. Vandensande, L. Alhonen, J. Janne, M. Szyf and A.C. Cuello, Alzheimer's disease linked mutations in amyloid precursor protein and presenilin 1 cause dysregulation of rat hippocampal proteins potentially involved in learning and memory before plaques and learning deficits occur (submitted).